The vaccine will be available to people in an affordable price range of Rs 200-400. Till now, HPV vaccines available in the Indian market are mostly manufactured by foreign manufacturers and cost around Rs 2,000 to Rs 3,500 per dose. Two vaccine variants available in India are Gardasi marketed by Merck) and Cervarix is marketed by Glaxo Smith Kline, according to NCBI
CERVAVAC has reportedly demonstrated a robust antibody response against all targeted HPV types, and in all dose and age groups. The DCGI granted market authorisation to SII for the manufacture of this vaccine after the Subject Expert Committee gave it a go-ahead following its successful Phase III clinical trials.